%2C+F-->%2E%22&type=AU">CarboneThe author names have been tagged as given names and surnames (surnames are highlighted in teal color). Please confirm if they have been identified correctly.-->, F-->., Adami, G-->., Liberale, L., Bonaventura, A-->., Bertolotto, M-->., Andraghetti, G-->., Scopinaro, N-->., Camerini, G.B., Papadia, F.S., Cordera, R., Dallegri, F., Montecucco, F-->.
| Zdroj: |
Diabetes & Metabolism; Sep2019, Vol. 45 Issue 4, p356-362, 7p |
| Témata: |
GASTRIC bypass, BARIATRIC surgery, TYPE 2 diabetes, OSTEOPONTIN, WEIGHT loss, DIABETES |
| Abstrakt: |
-->Bariatric surgery has been shown to effectively improve glycaemic control in morbidly obese subjects. However, the molecular bases of this association are still elusive and may act independently of weight loss. Here, our retrospective study has investigated the inflammatory molecule osteopontin (OPN) as a potential predictor of type 2 diabetes mellitus (T2DM) remission. -->Baseline serum levels of OPN were analyzed in 41 T2DM patients who underwent bariatric surgery. Anthropometric measures and biochemical variables, including insulin sensitivity indices (HOMA2), were assessed at baseline and at 1 and -->3 years after surgery. -->At baseline, patients who experienced T2DM remission had increased waist circumference, body weight and BMI, and higher serum OPN, compared with non-remitters. Patients with and without T2DM remission improved their lipid and glucose profiles, although insulin -->resistance indices were only improved in the T2DM remission group. In the overall cohort of both T2DM remission and non-remission patients, baseline circulating levels of OPN significantly correlated with reductions of body weight and BMI over time, and insulin sensitivity improved as well. However, only the HOMA2-%S remained independently associated with serum OPN on multivariate linear regression analysis (B: 0.227, 95% CI: 0.067–0.387, β = 0.831; P --> = 0.010). Baseline values of OPN predicted 3-year T2DM remission independently of body weight loss, lower BMI and duration of diabetes (OR: 1.046, 95% CI: 1.004–1.090; P --> = 0.033). -->Although larger studies are still needed to confirm our preliminary results, pre -->-operative OPN serum levels might be useful for predicting 3-year T2DM remission independently of weight loss in patients undergoing bariatric surgery. [ABSTRACT FROM AUTHOR] |
| : |
Copyright of Diabetes & Metabolism is the property of Masson Editeur and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
-->
| Autor: |
CarboneThe author names have been tagged as given names and surnames (surnames are highlighted in teal color). Please confirm if they have been identified correctly.-->, F-->., Adami, G-->., Liberale, L., Bonaventura, A-->., Bertolotto, M-->., Andraghetti, G-->., Scopinaro, N-->., Camerini, G.B., Papadia, F.S., Cordera, R., Dallegri, F., Montecucco, F-->. |
| Předmět: |
|
| Zdroj: |
Diabetes & Metabolism; Sep2019, Vol. 45 Issue 4, p356-362, 7p |
| Abstrakt: |
-->Bariatric surgery has been shown to effectively improve glycaemic control in morbidly obese subjects. However, the molecular bases of this association are still elusive and may act independently of weight loss. Here, our retrospective study has investigated the inflammatory molecule osteopontin (OPN) as a potential predictor of type 2 diabetes mellitus (T2DM) remission. -->Baseline serum levels of OPN were analyzed in 41 T2DM patients who underwent bariatric surgery. Anthropometric measures and biochemical variables, including insulin sensitivity indices (HOMA2), were assessed at baseline and at 1 and -->3 years after surgery. -->At baseline, patients who experienced T2DM remission had increased waist circumference, body weight and BMI, and higher serum OPN, compared with non-remitters. Patients with and without T2DM remission improved their lipid and glucose profiles, although insulin -->resistance indices were only improved in the T2DM remission group. In the overall cohort of both T2DM remission and non-remission patients, baseline circulating levels of OPN significantly correlated with reductions of body weight and BMI over time, and insulin sensitivity improved as well. However, only the HOMA2-%S remained independently associated with serum OPN on multivariate linear regression analysis (B: 0.227, 95% CI: 0.067–0.387, β = 0.831; P --> = 0.010). Baseline values of OPN predicted 3-year T2DM remission independently of body weight loss, lower BMI and duration of diabetes (OR: 1.046, 95% CI: 1.004–1.090; P --> = 0.033). -->Although larger studies are still needed to confirm our preliminary results, pre -->-operative OPN serum levels might be useful for predicting 3-year T2DM remission independently of weight loss in patients undergoing bariatric surgery. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect